In PDAC, Robo2 inhibits the activation of multiple downstream signaling pathways, such as MAPK and PI3K, by disrupting the interaction between TGF-β and HGF-MET, thereby impeding tumor growth [71, 72]. This evidence concerns the gene ROBO2 and neoplasm.